<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04105764</url>
  </required_header>
  <id_info>
    <org_study_id>elite NMB</org_study_id>
    <nct_id>NCT04105764</nct_id>
  </id_info>
  <brief_title>Deep NMB in Ambulatory Gynecological Laparoscopy</brief_title>
  <official_title>Deep Neuromuscular Blockade to Improve Postoperative Quality of Recovery in Ambulatory Gynaecologic Laparoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wahba bakhet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Elite medical center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gynecological laparoscopic surgery is commonly performed as an ambulatory basis for the aim
      of rapid discharge, reduce hospital stay with reduced costs and to improve postoperative QOR
      [1,2]. However, the creation of pneumoperitoneum during laparoscopy may cause postoperative
      pain and other physiological changes [3], which could influence the postoperative QOR
      negatively [4]. Poor postoperative QOR leads to prolonged hospital stay [5].
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Deep NMB is known to improve surgical conditions and pneumoperitoneium related complications
      in laparoscopic surgery [6,7,8,9]. However, it is unknown whether deep NMB improves
      postoperative QOR in ambulatory gynecological laparoscopy.

      Therefore, we designed a double blind randomised trial to compare the effects of deep and
      moderate NMB on postoperative QOR in ambulatory gynecological laparoscopic surgery. We
      hypothesized that deep NMB improves postoperative QOR, compared to moderate NMB. The primary
      outcome was postoperative QOR in POD1. The secondary outcome was quality of surgical
      conditions, pain scores, time to meet PACU and hospital discharge, and opioid consumption
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2016</start_date>
  <completion_date type="Actual">June 15, 2019</completion_date>
  <primary_completion_date type="Actual">November 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Quality of recovery-40 (QoR-40) questionnaire, which includes five general quality of life dimensions: physical independence (5 items), pain (7 items), .emotional state (9 items), psychological support (7 items), and physical independence (5 items). Each item was graded with a 5-point score: none of the time, some of the time,usually, most of the time and all of the time. The total score on the QoR- 40 questionnaire ranges from 40 to 200 representing, respectively, extremely poor to excellent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>During the length of hospital stay post surgery (on average 24 hours)</time_frame>
    <description>Visual analogue scale with its 0 to 10 score range: (0 (no pain) to 10 ( Severe pain)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Muscle Relaxation</condition>
  <arm_group>
    <arm_group_label>DEEP BLOCK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the deep NMB-group, a PTC of 1 to 2 twitches was maintained, and NMB was reversed with sugammadex at the end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the moderate NMB group, a TOF count of 1 to 2 was maintained and NMB was reversed with a combination of neostigmine and glycopyrolate at the end of surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>DEEP block to PTC 1-3</description>
    <arm_group_label>DEEP BLOCK</arm_group_label>
    <other_name>Neuromuscular blocker</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium bromide</intervention_name>
    <description>MODERATE block to TOF1-2</description>
    <arm_group_label>Moderate block</arm_group_label>
    <other_name>Neuromuscular blocker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I and II

        Exclusion Criteria:

          -  Neuromuscular disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Elite Medical Center</name>
      <address>
        <city>Kuwait</city>
        <zip>002</zip>
        <country>Kuwait</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kuwait</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>September 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>December 7, 2019</last_update_submitted>
  <last_update_submitted_qc>December 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Wahba bakhet</investigator_full_name>
    <investigator_title>LECTRURE</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bromides</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Neuromuscular Blocking Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Web</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>1 YEAR</ipd_time_frame>
    <ipd_access_criteria>Web</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

